@article{5da30e74c418480e8929e2b16f6d8fed,
title = "Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses",
keywords = "Activin, Myostatin, MDSC, Protein synthesis, Acute phase response, Physical activity, EXPERIMENTAL CANCER CACHEXIA, ACUTE-PHASE RESPONSE, TUMOR-BEARING MICE, SKELETAL-MUSCLE, PROTEIN-SYNTHESIS, ACTIVIN-A, PHYSICAL-ACTIVITY, II RECEPTORS, ACTIVATION, INHIBITION, 3121 General medicine, internal medicine and other clinical medicine, 3122 Cancers",
author = "Nissinen, {Tuuli A.} and Jaakko Hentil{\"a} and Fabio Penna and Anita Lampinen and Lautaoja, {Juulia H.} and Vasco Fachada and Tanja Holopainen and Olli Ritvos and Riikka Kivel{\"a} and Hulmi, {Juha J.}",
year = "2018",
month = jun,
doi = "10.1002/jcsm.12310",
language = "English",
volume = "9",
pages = "514--529",
journal = "Journal of cachexia, sarcopenia and muscle",
issn = "2190-5991",
publisher = "Wiley",
number = "3",
}